CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Clearmind Medicine Inc.
Financials through Q3 FY2026, quarter ended Jul 31, 2026
$6.00−0.26 (-4.15%)
Close on Oct 19, 2026
- Market cap
- $9.49M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Clearmind Medicine's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
1 buys · 4 sales
Net bought $205.92K
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Richard Abbe | 346,667 | 9.99% | 13G (passive) amendment | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Financial Lp Hrt | 10% owner | 184,845 | 116.93% | Jun 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Financial Lp Hrt 10% owner | Jun 16, 2026 | Sale | −22,139 | $3.31 | $73.28K | 81,353 |
| Financial Lp Hrt 10% owner | Jun 15, 2026 | Sale | −3,183 | $3.32 | $10.57K | 103,492 |
| Financial Lp Hrt 10% owner | Jun 12, 2026 | Sale | −2,102 | $3.36 | $7.06K | 106,675 |
| Financial Lp Hrt 10% owner | Jun 11, 2026 | Sale | −225,191 | $0.12 | $27.02K | 1,838,075 |
| Financial Lp Hrt 10% owner | Jun 10, 2026 | Buy | +2,159,052 | $0.15 | $323.86K | 2,063,266 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.